Nombre del producto:1,2,5-Oxadiazole-3-carboxamide, N-[(S)-(4,4-difluorocyclohexyl)[7-[(1S)-2-methoxy-1-[(4S)-2-oxo-4-(trifluoromethyl)-1-imidazolidinyl]ethyl]imidazo[1,2-b]pyridazin-2-yl]methyl]-4-methyl-

IUPAC Name:N-[(S)-(4,4-difluorocyclohexyl)({7-[(1S)-2-methoxy-1-[(4S)-2-oxo-4-(trifluoromethyl)imidazolidin-1-yl]ethyl]imidazo[1,2-b]pyridazin-2-yl})methyl]-4-methyl-1,2,5-oxadiazole-3-carboxamide

CAS:2452464-73-0
Fórmula molecular:C24H27F5N8O4
Pureza:98%
Número de catálogo:CM545836
Peso molecular:586.52

Unidad de embalaje Stock disponible Precio($) Cantidad
CM545836-50mg 1 Week ƿľľľ
CM545836-100mg 1 Week ƿIJȃƿ

Sólo para uso en I+D..

Formulario de consulta

   refresh    

Detalles del producto

Núm. De CAS :2452464-73-0
Fórmula molecular:C24H27F5N8O4
Punto de fusión:-
Código de sonrisas:COC[C@@H](N1C[C@H](NC1=O)C(F)(F)F)C1=CC2=NC(=CN2N=C1)[C@@H](NC(=O)C1=NON=C1C)C1CCC(F)(F)CC1
Densidad:
Número de catálogo:CM545836
Peso molecular:586.52
Punto de ebullición:
Nº Mdl:
Almacenamiento:

Category Infos

Imidazopyridazines
Potent IRAK-4 inhibitors have been reported by several groups including some structurally related benzimidazoles as well as alternative fused heterocycles such as the imidazopyridine and imidazopyridazine. Such compounds are reported to have IRAK-1 and IRAK-4 activity with varying degrees of selectivity.
Furazans
Incorporation of heterocycles into drug molecules can enhance physical properties and biological activity. Oxadiazoles are a class of five-membered heterocycles containing one oxygen and two nitrogen atoms with special biological activity and thermodynamic properties. 1,2,4- and 1,3,4-oxadiazoles are widely used in the development of bioactive molecules, but 1,2,5-oxadiazoles (furazans) are used relatively sparingly. Compared with 1,2,4- and 1,3,4-isomers, 1,2,5-oxadiazole has unique physicochemical properties and electronic effects. The furazan ring has a strong inductive effect, comparable to that of trifluoromethyl or tetrazolyl. The unique properties of furoxan can confer specific pharmacological activities to drug-like molecules.